Aspen Aerogels’ (ASPN) Buy Rating Reiterated at Roth Mkm

Roth Mkm restated their buy rating on shares of Aspen Aerogels (NYSE:ASPNFree Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The brokerage currently has a $36.00 price objective on the construction company’s stock, up from their previous price objective of $28.00.

A number of other research analysts have also recently commented on ASPN. Canaccord Genuity Group upped their target price on shares of Aspen Aerogels from $18.00 to $28.00 and gave the company a buy rating in a research report on Friday, May 3rd. B. Riley increased their price objective on Aspen Aerogels from $24.00 to $30.00 and gave the company a buy rating in a report on Friday, May 3rd. TheStreet raised Aspen Aerogels from a d+ rating to a c- rating in a report on Wednesday, March 6th. TD Cowen increased their price target on Aspen Aerogels from $30.00 to $36.00 and gave the stock a buy rating in a report on Wednesday, June 5th. Finally, HC Wainwright increased their price target on Aspen Aerogels from $20.00 to $25.00 and gave the stock a buy rating in a report on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of Moderate Buy and an average target price of $30.75.

View Our Latest Research Report on Aspen Aerogels

Aspen Aerogels Price Performance

Aspen Aerogels stock opened at $30.10 on Wednesday. Aspen Aerogels has a 52-week low of $5.32 and a 52-week high of $31.74. The firm has a market capitalization of $2.29 billion, a price-to-earnings ratio of -68.41 and a beta of 2.29. The company has a fifty day simple moving average of $23.77 and a 200-day simple moving average of $17.75. The company has a quick ratio of 3.29, a current ratio of 4.01 and a debt-to-equity ratio of 0.24.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its quarterly earnings results on Wednesday, May 1st. The construction company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.14. The firm had revenue of $94.50 million for the quarter, compared to analysts’ expectations of $73.04 million. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. On average, equities analysts anticipate that Aspen Aerogels will post 0.08 EPS for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young sold 256,944 shares of the firm’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $29.24, for a total value of $7,513,042.56. Following the completion of the sale, the chief executive officer now owns 502,855 shares of the company’s stock, valued at $14,703,480.20. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, SVP Keith L. Schilling sold 20,000 shares of the firm’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $26.84, for a total value of $536,800.00. Following the completion of the transaction, the senior vice president now owns 28,792 shares in the company, valued at $772,777.28. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Donald R. Young sold 256,944 shares of the firm’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $29.24, for a total value of $7,513,042.56. Following the completion of the transaction, the chief executive officer now owns 502,855 shares of the company’s stock, valued at approximately $14,703,480.20. The disclosure for this sale can be found here. Over the last quarter, insiders sold 3,832,103 shares of company stock valued at $91,679,369. 4.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ASPN. Maven Securities LTD purchased a new stake in Aspen Aerogels during the 3rd quarter worth about $860,000. AIGH Capital Management LLC purchased a new stake in Aspen Aerogels during the 3rd quarter worth about $15,067,000. Sargent Investment Group LLC boosted its stake in Aspen Aerogels by 5.4% in the 3rd quarter. Sargent Investment Group LLC now owns 271,710 shares of the construction company’s stock worth $2,337,000 after buying an additional 13,855 shares during the last quarter. UniSuper Management Pty Ltd boosted its stake in Aspen Aerogels by 13.5% in the 3rd quarter. UniSuper Management Pty Ltd now owns 1,083,836 shares of the construction company’s stock worth $9,321,000 after buying an additional 128,974 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. acquired a new stake in Aspen Aerogels in the 3rd quarter worth about $659,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Read More

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.